• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病非糖尿病患者中胰岛素抵抗的高患病率。

High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson's Disease.

机构信息

Department of Neurology, Cedar-Sinai Medical Center, Los Angeles, CA, USA.

Department of Neurosurgery, Cedar-Sinai Medical Center, Los Angeles, CA, USA.

出版信息

J Parkinsons Dis. 2018;8(2):259-265. doi: 10.3233/JPD-181305.

DOI:10.3233/JPD-181305
PMID:29614702
Abstract

BACKGROUND

Reduced glucose tolerance has been long recognized as a potential risk factor for Parkinson's disease (PD), and increasing scrutiny is currently being placed on insulin resistance (IR) as a pathologic driver of neurodegeneration. However, the prevalence of IR in PD is unknown.

OBJECTIVE

To determine IR prevalence in non-diabetic patients with PD and to correlate IR with other metabolic indicators, motor and non-motor symptoms (NMS) of PD, and quality of life (QoL).

METHODS

Non-diabetic patients with a diagnosis of PD were identified and tested for fasting insulin, fasting glucose, and HbA1c. Patients were also offered to take a battery of clinical tests (MoCA, NMSQ, and PDQ-39) and had their PD medications, height, weight, and other demographic features recorded. IR was defined as HOMA-IR≥2.0 and/or HbA1c≥5.7. IR abnormalities were correlated with BMI and demographic features, in addition to motor and NMS.

RESULTS

154 subjects (109 M, 45F, mean age 67.7±10.5) were included in this study. Mean HOMA-IR was 2.3±1.8. Ninety out of 154 (58.4%) subjects had abnormal IR. IR was more frequent in overweight and obese subjects (61.1% and 82.8% respectively) than normal weight subjects (41.5%). Multivariate analysis showed that BMI was the only significant predictor of IR (p < 0.0001). There was no significant correlation between HOMA-IR and MoCA, PDQ-39, and NMSQ scores.

CONCLUSIONS

IR is prevalent in PD and it correlates with BMI. A correlation between IR with cognitive and QoL measures cannot be determined on the basis of this sample.

摘要

背景

葡萄糖耐量降低早已被认为是帕金森病(PD)的潜在风险因素,目前人们越来越关注胰岛素抵抗(IR)作为神经退行性变的病理驱动因素。然而,PD 患者的 IR 患病率尚不清楚。

目的

确定非糖尿病 PD 患者的 IR 患病率,并将 IR 与其他代谢指标、PD 的运动和非运动症状(NMS)以及生活质量(QoL)相关联。

方法

确定诊断为 PD 的非糖尿病患者,并对其进行空腹胰岛素、空腹血糖和 HbA1c 检测。还向患者提供了一系列临床测试(MoCA、NMSQ 和 PDQ-39),并记录了他们的 PD 药物、身高、体重和其他人口统计学特征。IR 定义为 HOMA-IR≥2.0 和/或 HbA1c≥5.7。IR 异常与 BMI 和人口统计学特征以及运动和 NMS 相关。

结果

本研究共纳入 154 名受试者(109 名男性,45 名女性,平均年龄 67.7±10.5)。平均 HOMA-IR 为 2.3±1.8。154 名受试者中有 90 名(58.4%)存在异常 IR。超重和肥胖受试者(分别为 61.1%和 82.8%)的 IR 发生率高于正常体重受试者(41.5%)。多变量分析显示,BMI 是 IR 的唯一显著预测因素(p < 0.0001)。HOMA-IR 与 MoCA、PDQ-39 和 NMSQ 评分之间无显著相关性。

结论

IR 在 PD 中很常见,与 BMI 相关。基于本样本,无法确定 IR 与认知和 QoL 测量之间的相关性。

相似文献

1
High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson's Disease.帕金森病非糖尿病患者中胰岛素抵抗的高患病率。
J Parkinsons Dis. 2018;8(2):259-265. doi: 10.3233/JPD-181305.
2
Association of glycosylated hemoglobin (HbA1c) levels with Iinsulin resistance in obese children.肥胖儿童糖化血红蛋白(HbA1c)水平与胰岛素抵抗的关系
Afr Health Sci. 2014 Sep;14(3):533-8. doi: 10.4314/ahs.v14i3.6.
3
Dementia is associated with insulin resistance in patients with Parkinson's disease.痴呆与帕金森病患者的胰岛素抵抗有关。
J Neurol Sci. 2012 Apr 15;315(1-2):39-43. doi: 10.1016/j.jns.2011.12.008. Epub 2012 Jan 21.
4
Percentiles of fasting serum insulin, glucose, HbA1c and HOMA-IR in pre-pubertal normal weight European children from the IDEFICS cohort.来自IDEFICS队列的青春期前正常体重欧洲儿童空腹血清胰岛素、血糖、糖化血红蛋白和胰岛素抵抗指数的百分位数。
Int J Obes (Lond). 2014 Sep;38 Suppl 2:S39-47. doi: 10.1038/ijo.2014.134.
5
[Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].生长激素治疗下普拉德-威利综合征(PWS)患者碳水化合物代谢及胰岛素抵抗的变化
Wien Med Wochenschr. 2007 Feb;157(3-4):82-8. doi: 10.1007/s10354-007-0382-1.
6
Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection.慢性丙型肝炎病毒感染的非肝硬化患者胰岛素抵抗增加的机制。
J Gastroenterol Hepatol. 2003 Dec;18(12):1358-63. doi: 10.1046/j.1440-1746.2003.03179.x.
7
Similar Blood Glucose Pattern with Highest Peak at Minute 45 on Oral Glucose Tolerance Test Despite Higher Fasting Insulin and Insulin Resistance in Healthy Obese than Non-Obese Subject.健康肥胖者与非肥胖者相比,口服葡萄糖耐量试验 45 分钟时血糖峰值相似,但空腹胰岛素和胰岛素抵抗更高。
Acta Med Indones. 2022 Apr;54(2):210-217.
8
Size and shape of the associations of glucose, HbA, insulin and HOMA-IR with incident type 2 diabetes: the Hoorn Study.葡萄糖、HbA1c、胰岛素和 HOMA-IR 与 2 型糖尿病发病风险的关联的大小和形状:霍恩研究。
Diabetologia. 2018 Jan;61(1):93-100. doi: 10.1007/s00125-017-4452-7. Epub 2017 Oct 10.
9
Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.比较胰岛素抵抗指数与代谢综合征分类对预测超重和肥胖人群空腹血糖受损的发展:一项为期 3 年的前瞻性研究。
Int J Obes (Lond). 2009 Nov;33(11):1274-9. doi: 10.1038/ijo.2009.169. Epub 2009 Sep 1.
10
Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.口服葡萄糖耐量试验(OGTT)期间的胰岛素抵抗,但不是胰岛素反应,与肥胖非酒精性脂肪性肝病(NAFLD)的更差组织学结果相关。
Nutr Metab Cardiovasc Dis. 2020 Jan 3;30(1):106-113. doi: 10.1016/j.numecd.2019.08.001. Epub 2019 Aug 10.

引用本文的文献

1
A high triglyceride-glucose index correlates with cognitive impairment in Parkinson's disease: a cross-sectional study.高甘油三酯-葡萄糖指数与帕金森病认知障碍相关:一项横断面研究。
Front Neurosci. 2025 Aug 28;19:1620118. doi: 10.3389/fnins.2025.1620118. eCollection 2025.
2
Effects of gut microbiota on cognitive impairment in Parkinson's disease: a comprehensive Mendelian randomization and case-control study.肠道微生物群对帕金森病认知障碍的影响:一项全面的孟德尔随机化和病例对照研究。
Front Microbiol. 2025 Aug 25;16:1620449. doi: 10.3389/fmicb.2025.1620449. eCollection 2025.
3
The Influence of Insulin Resistance and Type 2 Diabetes on Cognitive Decline and Dementia in Parkinson's Disease: A Systematic Review.
胰岛素抵抗和2型糖尿病对帕金森病认知功能减退和痴呆的影响:一项系统评价
Int J Mol Sci. 2025 Aug 21;26(16):8078. doi: 10.3390/ijms26168078.
4
Triglyceride-glucose index predicts cognitive decline and striatal dopamine deficiency in Parkinson disease in two cohorts.甘油三酯-葡萄糖指数在两个队列中预测帕金森病的认知衰退和纹状体多巴胺缺乏。
NPJ Parkinsons Dis. 2025 Aug 13;11(1):240. doi: 10.1038/s41531-025-01100-1.
5
Aerobic exercise-induced changes in fluid biomarkers in Parkinson's disease.有氧运动引起帕金森病患者体液生物标志物的变化。
NPJ Parkinsons Dis. 2025 Jul 1;11(1):190. doi: 10.1038/s41531-025-01042-8.
6
Adherence to and a posteriori dietary patterns and risk of Parkinson's disease: a systematic review and meta-analysis of observational studies.坚持和事后饮食模式与帕金森病风险:观察性研究的系统评价和荟萃分析
Front Nutr. 2025 May 12;12:1600955. doi: 10.3389/fnut.2025.1600955. eCollection 2025.
7
Insulin resistance compromises midbrain organoid neuronal activity and metabolic efficiency predisposing to Parkinson's disease pathology.胰岛素抵抗损害中脑类器官神经元活动和代谢效率,易引发帕金森病病理改变。
J Tissue Eng. 2025 Jan 28;16:20417314241295928. doi: 10.1177/20417314241295928. eCollection 2025 Jan-Dec.
8
Insulin Resistance Is a Modifying Factor for Parkinson's Disease.胰岛素抵抗是帕金森病的一个修饰因素。
Mov Disord. 2025 Jan;40(1):67-76. doi: 10.1002/mds.30039. Epub 2024 Nov 5.
9
Aging and "Age-Related" Diseases - What Is the Relation?衰老与“年龄相关”疾病——二者有何关系?
Aging Dis. 2024 Jun 28;16(3):1316-1346. doi: 10.14336/AD.2024.0570.
10
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.2型糖尿病对帕金森病病因的影响。
Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358.